Alemtuzumab‐induced immune‐mediated thrombotic thrombocytopenic purpura: A newly described drug‐related autoimmune disease. - Bourdin, V.; Fossé, Q.; Lambotte, O.; Joly, B.; Coppo, P.; Anguel, N.; Labeyrie, C. (British Journal of Haematology, 2024)